Increasing incidence of multidrug resistant Pseudomonas aeruginosa in inpatients of a tertiary care hospital.

Simple item page
dc.contributor.authorPrakash, Ved
dc.contributor.authorMishra, Prem Prakash
dc.contributor.authorPremi, H K
dc.contributor.authorWalia, Apoorva
dc.contributor.authorDhawan, Shikha
dc.contributor.authorKumar, Abhishek
dc.date.accessioned2015-11-10T05:46:18Z
dc.date.available2015-11-10T05:46:18Z
dc.date.issued2014-10
dc.description.abstractBackground: Pseudomonas aeruginosa is an important pathogen isolated from various clinical infections. The occurrence of multidrug-resistant (MDR) Pseudomonas aeruginosa strains is increasing worldwide and limiting our therapeutic options resulting in high mortality. We aim to study the incidence of multidrug resistant Pseudomonas aeruginosa in inpatients from various departments along with rate of nosocomial infections. Methods: A cross sectional study from January 1, 2013 to December 31, 2013. A total of 167 Pseudomonas aeruginosa were isolated from 764 clinical specimens. The isolates were identified by standard microbiological techniques. The antibiotic susceptibility was done by Kirby Bauer method. Results: The highest number of isolates were from pulmonary samples n=90 (53.89%) followed by pus n=48 (28.74%). Overall, 39 (23.36%) isolates were nosocomial. The nosocomial isolates were mainly isolated from department of surgery, orthopaedics, obstetrics & gynaecology followed by others. Among 167 isolates screened, 53 (31.73%) were found to be MDR (resistant to ≥3 classes of antipseudomonal agents). The resistance was most against cephalosporins [Cefepime (65.26%), cefotaxime (60.47%)], fluoroquinolones [Ciprofloxacin (46.1%), levofloxacin (31.87%)] aminoglycosides [Amikacin (37.72%), gentamicin (31.13%)] followed by ureidopenicillins and carbepenems. About 56.75% isolates were suspected Metallo β lactamases producers. Conclusion: The study suggests that the incidence of nosocomial infection by multidrug resistant Pseudomonas aeruginosa is increasing globally especially the Metallo Beta lactamases producing strains. So there is a continuous need of conduction of surveillance programmes to formulate rational treatment strategies to combat this emerging challenge.en_US
dc.identifier.citationPrakash Ved, Mishra Prem Prakash, Premi H K, Walia Apoorva, Dhawan Shikha, Kumar Abhishek. Increasing incidence of multidrug resistant Pseudomonas aeruginosa in inpatients of a tertiary care hospital. International Journal of Research in Medical Sciences. 2014 Oct-Dec; 2(4): 1302-1306.en_US
dc.identifier.issn2320-6071
dc.identifier.issn2320-6012
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/165430
dc.language.isoenen_US
dc.source.urihttps://www.msjonline.org/?mno=164282en_US
dc.subjectPseudomonasen_US
dc.subjectIncidenceen_US
dc.subjectNosocomialen_US
dc.subjectAntibioticen_US
dc.subjectResistanceen_US
dc.titleIncreasing incidence of multidrug resistant Pseudomonas aeruginosa in inpatients of a tertiary care hospital.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijrms2014v2n4p1302.pdf
Size:
415.45 KB
Format:
Adobe Portable Document Format
Description:
Research article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
International Journal of Research in Medical Sciences